REPL

NASDAQStock

Replimune Group, Inc.

$7.67-0.26 (-3.23%)

52-Week Range

$2.81
$12.63

Key Stats

Market Cap

632.9M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.77

Volume

761.7K

Avg Volume

1.4M

Performance

1M

-2.32%

3M

-23.82%

6M

+33.69%

YTD

-14.83%

1Y

-36.09%

3Y

-61.83%

5Y

-77.73%

Price Chart

ETF Exposure

REPL is held by 63 ETFs

ETFFund NameWeight
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
PreviousPage 2 of 2

About REPL ETF Exposure

Replimune Group, Inc. (REPL) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 632.9M, REPL is a widely held institutional stock. The stock currently trades at $7.67. Investors can gain exposure to REPL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold REPL, sorted by portfolio weight.